Insights On Clinical Technologies

  1. The Future Of Diabetes Treatment

    For those of us who are living with or who have a family member living with type 1 diabetes, we are probably well acquainted with the promises of pancreas transplants, islet stem cell therapy, and other science fiction. But what types of advances can we realistically hope for in the next 5 to 10 years? Or maybe even in the next 2 years?

  2. A More Complete Scope For Advances in Women’s Health

    The field of medicine pertaining to women’s health is rapidly growing to include the study of both specific conditions that only manifest in women and also maintenance of well-being and quality of life during the unique but normal life cycles experienced by women. Fortunately, we are beginning to understand the implications of women-specific needs on mental and emotional health, and new devices are being designed to cater to these needs.

  3. Five New Tech Options To Use In Your Virtual Trial

    At Biorasi, we have been wondering if it is really possible to design a trial to be completely virtual and what that would entail. Read more about some interesting technologies that could be put to use in a virtual, or maybe semi-virtual, trial.

  4. How A CRO-EDC Partnership Got Results For Study Sponsors

    To deliver consistent results and ultimately create lasting relationships with sponsors, ARA needed fast and flexible eClinical tools. Medrio offered the ability to set up studies easily, collect data accurately, and make mid-study changes without study downtime saves their clients time and money - and increases the likelihood of repeat business and referrals.

  5. A Successful DDC Implementation That Any Organization Should Aspire To

    Learn how a Phase I unit in Australia leverages Medrio DDC to reduce paper usage by 95% and monitoring visits by 50%. This case study provides holistic insight into DDC vendor selection, implementation, and results.

  6. Key Findings From The EMA’s Qualification Opinion On DDC

    The EMA’s qualification opinion on Direct Data Capture (DDC) is a huge regulatory development for the clinical research industry. Read our white paper for a quick understanding of the major points in the opinion, and of how DDC improves data accuracy, monitoring, and more.

  7. Advanced Analytics For The Monitoring Of Clinical Trials

    Clinical research generates a massive amount of data. Unfortunately, because of the way most clinical data programs currently work, much of these data are not used to their fullest extent; they are simply filed away. This white paper will focus on the benefits provided by a unique and advanced analytical approach to study monitoring beyond the minimum necessary RBM approach.

  8. An Overview Of The ICH E6 (R2) Guideline

    While the revisions to the guideline mainly impact sponsors, technology providers and contract research organizations need to be aware of the changes and make adjustments to operational procedures, documentation practices, quality approaches and computerized system functionality.

  9. The Future Is Here For Clinical Trials, And It Introduces New Risks

    Mobile phone apps and wearable devices have a lot of potential to improve clinical studies. However, the rules governing them are complex, varied, and not fully developed. It is important to be vigilant and remember best practices before rushing out to jump on the latest and greatest.

  10. The Quintessential Guide To Planning A Successful Clinical Trial

    Clinical trials are complex undertakings, with complex planning required. Success or failure is often determined long before the trial even gets underway. Biorasi’s quintessential guide to clinical trial planning helps program managers and operations directors identify and resolve the sticking points that can risk the timely completion of their clinical trials and programs.